The author has summarised the science in his published works which contained chemistry. biochem· istry and molecular biology related to pteridines as a dedication to Professor Wol(gang Pt1eidcrcr n n the occasion of his seventieth birthday. These publications spanned the period 1977-199 7.
Introduction
I first met Professor Wolfgang Pfleiderer in 1965 when he spent several months of sabbatical leave in Professor Adrien Albert's Department of Medical Chemistry, John Curtin School of Medical Research, at the Australian N ational University. After his return to Stuttgart Wolgang was appointed foundation Professor at the then new University of Konstanz. There he built a Chemistry School which soon became internationally famous for research in heterocyclic chemistry with particular emphasis on pteridines, purines and related heterocycles, and later also on nucleoside, nucleotide and polynucleotide chemistry of biological importance . To many, including m yself, Pfleiderer's Konstanz School became a Mecca for scientists with special interests in these areas of research. I visited the Konstanz School on several occasions, and each time I returned to Australia § Author to whom correspondence should be addressed .
with renewed vigour and new ideas for continuing with my own research programs. It was Wolfgang's work on pteridines in particular which stimulated my interest to work with pteridines even though research in pteridine chemistry was taking place all around me with the work of Adrien Albert and Des Brown and their coworkers. Over the years Wolfgang Pfleiderer I s work has been an inspiration to me, during which time he also had an important influence on my career. In gratitude I wish to dedicate this review to him on the occasion of his seventieth birthday, for his help in advancing m y career, for his unfailing friendship and for his warm and generous hospitality during my visits of Konstanz.
My active research with pteridines began about twenty years ago in 1976. I felt that work on their biological aspects would be very fruitful, and also that it was a most appropriate field for someone employed in a medical research institution. I published my first paper on pteridines in 1977 (1) which described the methylation of 6-methylpte-rin. The manner in which my work in the area of pteridines developed meant that I had to learn the principles of biochemistry and of pterin -requmng enzymes. Later the biochemical work 11100'ed into the realms of the molecular biology o f these enzymes. The latter meant that yet again I had to learn another scientific discipline with entire/\-diftcrent experimental techniques. What was interesting was that I did tlns in an institution \\ here it was possible to change research direction ,:lI1d \"ork in several disciplines at the same time \"ithout seriously jeopardising career. Alas this is no longer possible, at least not to the same degree. In this dedication I have summarised my adyentures in the chemistly, biochemistry and molecular biology of pteridines and some enzymes \\'hich need them as cofactors.
Chemistry
The majority of pteridines found in nature possess the 2-aminopteridin-4( 3H)-one structure because of the way in which they are biosynthesised 2 ). It was Pfleiderer (3) who suggested the generic term pterins for this class of pteridines since th c natural pteridines were called pterins . Our " 'ork concentrated on 6-substituted pterins since n,lturc has placed the substituents in that position 111 the early stages of biosynthesis. Of these pterins, the derivatives that are reduced in the pyrazine ring, e.g. 7,8 (3H) -and 7,8 (6H)-dihydro and 5,6,7,8-tetrahydro-pterins are the enzymically active ones. In order to explore the substrate stereospecificities of reduced pterins in their enzymic reactions we first studied the methylation of 6-methylpterin ( 1 ) . The work was assisted greatly b y earlier studies on the methylation of pterins and by the then recently available technique of lH NMR spectroscopy. We found that methylation in alkaline medium provided a 2: 1 mixture of 3,6-and 1,6-dimethylpterins which we identified. In methanol, on the other hand, methylation gave a 1 : 11 mixture of 1,6-dimethyl and 6, 8-dimethypterins as their hydriodide salts. Catalytic reduction of these methyl-pterins provided the 5,6,7,8-tetrahydro derivatives in very good yields. The stereochemistry of the catalytic reduction of 6-methylpterin was better studied by reducing 7-deuterio-6-trideuteriomethyl-pterin with hydrogen, and the product was a 0 .8:1 mixture of cis-and trans-7 -deuterio-6-trideutel;omethyl-5 ,6,7,8 -tetrahydropterins (by NMR). The 2,4-diamino analogue gave a 1 :1 mixture of Ci5-and trans-2,4-diamino-7 -deuterio-6-trideuteriomethy l-5 ,6 ,7,8-Pteridines/ Vol. 9 / No. 2 :\rIllarego: A Twe nty year association with pteridines tetrahydropteridines. Similar catalytic reduction of 6, 7-dimethylpterin provided only the cis-5,6,7,8-tetrahydropterin. With sodium in ethanol on the other hand a 1: 1 mixture of cis-and trans-6,7 -dimethyl-5,6,7,8-tetrahydropterin was produced (4 ) .
The methylation of 6-methyl-5,6,7,8-tetrahydropterin attracted our attention as it would produce more stable methylated derivatives which could be tested as substrates of dihydropteridine reductase, and because the products could give us some insight into the tautomeric structure of quinonoid-dihydropterins (see below) . The products \vere also required for degradation and determination of the absolute configuration of ( + ) and ( -) 6-methyl-5,6,7,8-tetrahydropterins which we had obtained by optical resolution of their 25, 35-di-Obenzoy ltartrate salts ( 5) . We also obtained the ( -)-enantiomer by reduction of 6-methyl-7,8(3H)-dihydropterin with dihydrofolate reductase from calf liver in the presence ofNADPH (6) .
In the presence of three equivalents of sodium hydroxide and excess of methyl iodide, 6-methyl-5,6,7,8-tetrahydropterin dihydrochloride first produced the 1 ,3,6-trimethyltetrahydro -pterin which was further methylated to 1,3,5,6-tetramethyltetrahydropterinium iodide with the order of methylation being at Nl, N3 then N5. N-5 Demethy-!ation occurred w hen the tetramethyl compound was subjected to Dowex 50 W chromatography in the presence of 3N aqueous ammonia, or N sodium h ydroxide or aqueous ammonia alone, to produce the 1,3 ,6 -trimethyl-5,6,7,8-tetrahydropterinium cation. Interestingly, the methylation of 5,6-dimethyl-5,6,7,8-tetrahydropterin 1 with sodium hydroxide and trideuteriomethyl iodide resulted in the intermediate cation 2, and then removal of the unlabelled methyl group from N5 and redistribution of the unlabelled 5-methyl group equally to N1 and N3 to pro\'ide the pterin 3 . Thus it had methylated at "5 with a C D ., group and alkylated itself at Nl and N3 (Scheme 1). By using different methylated tetrahydropterins and CD3I it was shown that N3 methylation was more efficient than Nl methylation possibly due to the differences in nucleophilicity and steric requirements for alkylating the nitrogen atoms. These studies had allowed us to propose a mechanism by which the cofactor 5-methyl-5,6,7, 8-tetrahydrofolic acid acts as an enzymic methylating agent since it was known that when the 5-methyl group was labelled (with 14C), the label was enzymically transferred to methylcobalamin and meithonine. For this to occur either a positive charge was introduced to the pyrimidine ring of 5-methyl-5,6,7,8-tetrahydrofolic acid which would make the methyl group more readily transferred ( as in the de methylation with Dowex 50 Wand ammonia a-"'()\"e ), or a positive charge was placed on N5 (say :-"\ enzymic acylation) making the cofactor a good methylating agent (see Scheme 1) (7) . In this study 1,3,6-trimethyl-and 1,3,5,6-tetramethyl-5,6,7,8-tctrahydropterinium chlorides were found to be considerably more stable to aerial oxidation than 1,6-, 3,6-, 5,6-, 6,7-, 6,8-dimethyl-, and 1,5,6-trimethyl-5,6,7 ,8-tetrahydropterins.
The absolute configuration of (-)-6-methyl-5,6, 7,8-tetrahydropterin obtained from the reduction of 6-methyl-7 ,8( 3H)-dihydropterin by dihydrofolate reductase was shown to be S at C6 4 by a series of methylations, degradations and syntheses \\'hich correlated it with S-( + )-1 ,2,4-trimethylpiperazine dihydrochloride 5 derived from S-alanine ( 6, 8) . By analogy, the absolute configuration at C 6 of natural tetrahydrofolic acid (6) should be S, and this was confirmed by X-ray crystallography of the related 5,10-methylenetetrahydrofolic acid (9 ) . While we were working with tetrahydropterins we examined in detail the 13C NMR spectra and the IH_13C coupling constants in order to determine the conformations of the 6-substituents in aqueous solution. The NMR data demons-57 trated that the tetrahydropyrazine ring was in a half-chair conformation in most of the compounds and that the 6-substituent in 6-methyl-, 5, 6-dimethyl-, 6,7-dimethyl-and 6,7,7-trimethyl-5, 6,7,8-tetrahydropterins, tetrahydrofolic acid and 5, 10-methylenetetrahydrofolic acid were respectively ca 100, 45, 50, 70 and 100% in the equatorial conformation. The 30% axial conformation of the 6-pmethylarninobenzoylglutamic acid group in tetrahydrofolic acid was stabilised by the intramolecular stacking forces betvveen the benzene ring and the pyrimidine ring (10) .
NMR studies were extended to investigations of the diastereoisomers of 5,6,7,8-tetrahydro-Lbiopterin at C6 and their tetraactyl derivatives ( 11) . For the preparation of these a convenient synthesis of L-erythro-biopterin (12) on a fivegram scale was used which was an adaptation of Sugimoto and Matsuura 's synthesis (13) . Catalytic reduction of biopterin in trifluoroacetic acid gave a 3:1 mixture of natural (6R) and non-natural (6S) tetrahydrobiopterins which were separated by acetylation and crystallisation of the 2,5,l',2'-tetraactyl derivatives. Catalytic reduction of 2, I' ,2'-triacetylbiopterin in ethanol on the other hand gave a 1 :3 mixture of (6R) and (6S) 2,5,l',2'-tetraacetyl-tetrahydrobiopterins after further acetylation, which were readily separated. Thus we prepared large amounts of pure natural and non-natural tetrahydrobiopterin hydrochlorides after mild acid hydrolysis of the acetates ( 11) . The I H NMR spectra at 270 MHz of the hydrochlorides in aqueous solution, and of the tetraacetates in CDCI., were very revealing and were distinctly different for each diastereoisomer, and were used to identifY them . The coupling constants in the spectra showed that the tetrahydropyrazine rings in the tctrahydrobiopterins were in the half-chair conformation with the 6-dihydroxypropyl side chain equatorially disposed. The spectra also showed that the side chain of the 6R-isomer 7 was more freely rotating and thus distinctly different from that of the 65-isomer 8 which appeared to be restricted. The latter was confirmed by raising the temperature in the NMR experiment whereby the signals for H6, H7 cq , HI' and H2' came closer together as in the 6R-isomer. If the conformations of the side chains in the respective quinonoid species, e.g. 9 for the S-isomer, were like those of the tetrahydro compounds 7 and 8, as was shown to be the case in 6-methyl-7 ,8( 6H)-dihydropterin (14) , then the restricted conformation of the side chain in the 65-isomer 9 must place it in an orientation whereby it could be released easily in the acid-base catalysed rearrangement of the quinonoid dihydropterins to the 7,8(3H)-dihydro tautomers (11) . This may be the reason why (65)-quinonoid-7, 8 ( 6H) -dihydrobiopterin loses its side chain ca eight times faster than the natural 6R-diastereomer in aqueous buffer (15) . The lH NMR spectra of the tetraacetyl-tetrahydrobiopterins in CDCl 3 were different, showing that the tetrahydropyrazine rings were in twisted half-chair conformations with the dihydroxypropyl side chains in pseudo-axial orientations. The conformations of the diasteriomers were, however, different enough to produce characteristically different spectra (11) . The conformations of (-)-(25)-2-methyl-l,2,3,4-tetrahydroquinoxaline, (-)-( 65)-6-methyl-s,6,7,8-tetrahydropterin and natural tetrahydrobiopterin as deduced by NMR spectroscopy were very similar in dilute aqueous acid solution as were their negative circular dichroism spectra (0 248, 263 and 268 nm respectively). From these data the absolute configuration of natural tetrahydrobiopterin at C6 was deduced as R (12) . This absolute configuration was later confirmed by X-ray crystallography (16, 17) .
The oxidation products of tetrahydropterin cofactors by phenylalanine hydroxylase were shown by the extensive studies of Kaufinan (18) to be a new class of dihydropterins named quinonoid dihydropterins. He gave them the structure 11. They were unstable species which rearranged, by acid-base catalysis, to the tautomeric stable dihydro species 12. The enzyme dihydropteridine reductase uses the quinonoid dihydropterins 11 specifically as cofactors, whereas dihydrofolate reductase uses the stable dihydro tautomers 12 specifically, in the form of 7, 8( 3H)-dihydrofolate. The former enzyme is much more tolerant to changes in the structure of the pterin cofactor. Kaufman's structure for quinonoid dihydropterins 11 was confirmed by later work of others in every detail except for the exocyclic strucPteridines/Vol. 9/ No. 2 Armarego: A Twenty year association ,..nth pteridines ture of the 2-imino group (para-quinonoid tautomer). Although this was consistent with the oxidation of p-phenylene diamine to quinone-l,4-diimine by inorganic oxidants and by peroxidase and hydrogen peroxide, we felt that in a fused pyrimidine system as in dihydropterin the 2-amino ortho-quinonoid tautomer 13 should be much more stable. We went to great lengths to prove :j: 
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H that this was so because it was an important point for the mechanism of reduction by dihydropteridine reductase where hydride reduction by NADH was assisted by a proton donating group on the enzyme. In structure 11 the proton would be transferred to the exocyclic 2-imino nitrogen atom whereas in structure 13 it would be transferred to N3 of the pyrimidine ring. The comparative rates of oxidation by molecular oxygen of 2-amino-cis-6,7 -dimethyl-s ,6,7 ,8-tetrahydropteridin-4(3H)-one, its 2-methylamino-, 2-dimethylamino-3-methyl-and 8-methyl derivatives and their 6,7 -dideuterio derivatives to the respective quinonoid 7,8(6H)-dihydropterins, the rates of rearrangements of the latter to the corresponding 7, 8(3H)-dihydropterins, as well as the rates of nonenzymic oxidation of NADH by the quinonoid dihydropterins strongly supported the ortho-quinonoid structure 13 (19, 20) . Structure 13 gained further support when it was shown that the quinonoid species in which the 2-amino group was replaced by a methyl, methylthio or methylamino (21) , or a hydrogen atom as in 7,8(6H)-dihydropteridin-4-ones (22) were all viable substrates for dihydropteridine reductase. Moreover, quinonoid 2 -methyl-2 -desamino-7 ,8 ( 6H) -dihydro-biopterin and 2-methyl-2-desamino-7 ,8( 6H)-dihydroneopterin were also substrates for the reductase (23) . Finally the 15N NMR chemical shifts of the quinonoid species of cis-6,7-dimethyl-7,8(6H)-dihydropterin labelled at the nitrogen atoms in the NH2 (33%), Nl (33%), N3 (33%) and N5 (95%), and separately at the ~H2 (95%), with 15N in aqueous buffer at near-neutral pH were completely consistent \\ith th e u nho -qllinonoid structure 13 with the excxh: l.i-: amino group (24) . The formulae of quinolloid 7 ,8( 6H)-dihydropterins should be drawn as in 13 unless there is very strong experimental evidence to the contrary for a particular compound. All this work has been summarised in a review (25) . The tautomerisation of quinonoid 7 ,S( 6H)-dihydropterins 13 to the thermodynamically more stable 7,8(3H)-dihydropterins 12 results in cleavage of the C6-H bond and is subject to a large deuterium isotope effect of -10 or more when H6 is replaced by deuterium . However if an OH or an NH2 group on a carbon substituent on C6 as in quinonoid dihydrobiopterin 9 or 6-hydroxymethyl-or aminomethyl-7,8(6H)-dihydropterin then the C6 side chain is lost in preference to H6 and provides in each case 7,8(3H) -dihydropterin 10 (15, 26, 27) . This dihydropterin undergoes covalent hydration [reversible water addition across a C=N, a phenomenon encountered in nitrogen heterocyclic chemistry (2S)] across C6=N5 to provide 6-hydroxy-5,6,7,S-tetrahydropterin which after oxidation to quinonoid 6-hydroxy-7 ,S( 6H)-dihydropterin (13, R=OH, a substrate for dihydropteridine reductase) undergoes rearrangement to 7, 8-dihydroxanthopterin 12, R=OH (27) . These reactions explain the presence of 7,S-dihydroxanthopterin as a urinary metabolite from children who are deficient in dihydropteridine reductase (a malignant variant of phenylketonuria) as a result of the accumulation and then degradation of the natural cofactor (6R-isomer of 9) (29) . For some of the above studies we synthesised 6-hydroxymethylpterin from 2-acetamido-6 -methylpteridin-4(3H)-one by lead tetraacetate oxidation in 85% overall yield from 6-methylpterin. (30) . The condensation of 2,5,6-triaminopyrimidin -4( 3H)-one with methyl glyoxal (Isay synthesis) at 0-5°C increased the ratio of 6-to 7-methylpterin to 9:1 (30) .
There was a demand for a stable quinonoid 6-substituted pterin which was fulfilled by our synthesis of 6,6-dimethyl-5 ,6,7 ,8-tetrahydropterin . This was achieved unambiguously by addition of methyl lithium across the C5-N6 double bond of trimethylsilylated 6-methyl-7,S-dihydropterin followed by acid hydrolysis. The usual oxidants at near-neutral pH converted it to 6,6-dimethyl-7, 8( 6H)-dihydropterin which was considerably more stable than quinonoid 6-methyl-7,S(6H)-dihydropterin (31) . Another compound that we prepared was quinonoid 6,6,8- (33) .
A variety of 6-and 7-alkyl pterins (e.g. ethyl, propyl, hexyl, phenethyl, neopentyl) were synthesised mostly by modified Isay syntheses for the preparation of their 5,6,7,S-tetrahydro derivatives as lipophilic pterins to substitute for tetrahydrobiopterin which had difficulty in penetrating the blood-brain barrier (34). The respective quinonoid dihydropterins (all of which were active substrates) were prepared, and their rates of rearrangement to the stable dihydro tautomers, e.g. 12, were determined. The presence of a 6-alkyl group reduced the rates of rearrangements more than four fold , e .g . 7-substituted 7,8(6H)-dihydropterins rearranged much faster than their 6-substituted isomers (34). A further number of 6-alkylpterins were synthesised for enzymic evaluation, but in this case the ambiguous Isay synthesis was avoided by condensing 2-amino-6-chloro-5-nitropyrimidin-4(3H)-one with ethyl aamino methyl ketones, all prepared from the respective ethyl 4-alkyl-3,1-oxazole-5-carboxylates, followed by reduction and cyclisation to the pterin (35) . Some of the chemical and biological properties of reduced pterins which we investigated before 1983 were summarised in a lecture (36) . 
Biochemistry
Our biochemical work focussed on enzymes that required reduced pterin cofactors and which were affected in inherited metabolic diseases such as in phenylketonuria and its variants, and in ether lipid metabolism. A lot of our attention was attracted to dihydropteridine reductase (DHPR) because deficiency of this enzyme in children can be lethal (37). We prepared pure DHPRs from sheep liver (5, 33, 38) , monkey liver (33,39), human liver (5, 15) and human brain (21, 22, 23, 40, 41) . The DHPRs from mammalian brain were generally easier to purifY than trom liver probably because the latter organ has many oxidoreductases which have closely similar properties to DHPR. The enzymic reaction is shown in Scheme 2 and uses NADH as the hydride source. Since the quinonoid dihydropterins used in this reaction were relatively unstable they were always generated in situ trom the respective 5,6,7 ,8-tetrahydropterins (which could be stored for extensive periods) by oxidation, usually with peroxidase and hydrogen peroxide or potassium ferricyanide, but other oxidants have been used (37). The conditions for this oxidation in the assay were such that it was fast (not rate limiting) and the rearrangement of the quinonoid substrate to the respective enzymically inactive 7, 8 ( 3H)-dihydropterin was negligible under the reaction conditions. Although non-enzymic reduction of quinonoid dihydropterins by NADH does occur [and we have measured them. on several occasions (19, 22, 33, 34) ], these rates were generally at least one order of magnitude slower than the enzymic rate. One should make sure that this is so before studying the enzymic reaction. The DHPRs that we prepared were used to determine what substitution and stereochemistry of substituents on pterin substrates could be tolerated by the enzyme. The kinetics using a large variety of pterin substrates were determined and the kinetic parameters \"Km, Vmax ane V /K.) were usee as a measure of substrate viability.
DHPRs were not very sensitive to the absolute configuration at C6, as shown by the kinetic parameters for 6R-and 6S-quinonoid 6-methyl-7, 8(6H)-dihydropterins (5,39) and 6R-and 6S-quinonoid 7 ,8( 6H)-dihydrobiopterin ( 15 ) where compounds with either configuration at C6 were almost equally good substrates. However those with the natural configuration were marginally better due to the smaller Km values. The configurational mobility of the tetrahydropyrazine rings in these compounds was such that the 6-side chain could be placed in the equatorial conformation Irrespective of absolute configuration at C6 (see structures 7 and 8). Quinonoid dihydropterins with one alkyl substituent at C6 or C7 were very good substrates, indeed judging by the V /K values substrates with alkyl groups such as ethyl, n-propyl, nhexyl, phenethyl as well as neopentyl were better substrates than natural quinol1oid dihydrobiopterin ( 33 
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trans capacity at the active site than the cis-isomer. This is consistent with an active conformer with the 6-and 7 -methyl groups in the equatorial conformation, i.e. structure 17 and not 18 (5) . This was confirmed by the considerably decreased substrate activity (from V / K values, the first order rate constants at low substrate concentrations) in quinonoid 6,6-dimethyl-(34,39) and 6,7,7 -trimethyl-( 5,39) 7,8 (6H)-dihydropterins caused mainly by increase in the Km values (probably due to decreased binding). With these two substrates, the former ( Km 634 /-lM with monkey liver DHPR) has a much higher Km value than the latter (Km 138/-lM with monkey liver DHPR), consistent with greater obstruction at C6 near the reactive nitrogen atom N5 . Substituents at C6 and/or C7 were not strictly required for enzyme activity as shown by the activity of quinonoid 7,8(6H)-dihydropterin (as its 6,6,7,7 -~H4-derivative), and even the completed h~'dropyrazine ring was not obligaton ,,5 qllinonoid 2,6-diamino-5-iminopyrimidin--± -ol1c 19 was a good substrate (33 because quinonoid dihydropterins such as 14 were active substrates (see above, 22). Also the enzyme can tolerate a 2-methyl group, as in 20, R=R'=R"= Me, a 2-methylthio group, as in 20, R=MeS, R'= R" =Me, and a methylamino group as in 20, R= MeNH, R'=R"=Me (see above, 21) . The quinonoid dihydropterin 21, R=H, R'=Me with an 8-methyl group was also a substrate, altllough weak ~ 1 ), but the related compound 21, R=R'=Me \\J.s devoid of activity [in fact it was a weak inhibitor of DHPR (32) ]. The latter compound \\'as however a relatively good substrate for phendalanine hydroxylase but not for tyrosine hydroxylase ( 32) . These data exclude the ortho-quinonoid structure 22 on the ground that this compound, i.e. 21, R=H,R'=Me, would have a full positive charge on N8 and should be very reactive towards NADH. A 2-0H group was not acceptable to the enzyme because quinonoid 6-methyl-7, 8(6H)-dihydrolumazine was not a substrate, nor an inhibitor, of DHPR (22) .
All the tetrahydropterins with lipophilic side chains at C6 (methyl, ethyl propyl, hexyl, neopentyl, phenethyl) gave quinonoid species which were as good or better substrates for DHPR from V / K values than the natural cofactor (see above and ref. 34). These were found also to be active substrates for phenylalanine hydroxylase (but less than the natural cofactor from V / K ), tyrosine hydroxylase (but less than the natural cofactor from V /K) and tryptophan hydroxylase (but better than the natural cofactor from V max) (35). The overall best substrate was 6-propyl-5,6,7,8-tetrahydropterin and it should be a good candidate for tetrahydro-biopterin cofactor therapy for variant forms of phenylketonuria and for Parkinson's dise- 61 ase. No discernible eftect was observed when tetrahydrobiopterin was given orally in small doses to patients with early Parkinson 's disease (42). The structure-activity studies of quinonoid dihydropterins with dihydropteridine reductase were reviewed in 1989 (43).
We have resolved the stereospecificity of the pyridine nucleotide cofactor by showing that the 4-proS hydrogen atom of NADH was exclusively transferred to NS of quinonoid cis-6,7 -dimethyl-7, B( 6H)-dihydwpterin by human and sheep liver DHPRs (38). This was different from the stereospecificity with dihydrofolate reductase in which the 4-proR hydrogen of NADPH was transferred to C6 of 7,
All the above data and conclusions were consistent with the more recent determinations of the X-ray crystal structures of DHPR proteins, expressed in E. coli, with the amino acid sequences of DHPR from rat (45) and human (from sitedirected mutagenesis of rat DHPR eDNA, 46) but without the N-amino terminal protecting groups found in the natural enzymes. The X-ray structures showed clearly that there was enough space to accommodate the various substituents on tlle quinonoid dihydropterin substrates discussed above, and demonstrated that enzyme kinetic data provide very useful information about the active site of an enzyme. While looking for inhibitors which could be infused into the crystals of the human dihydropteridine reductase-NADH binary complex, we prepared 3-substituted 6-methylpyrimido[ 4,S-e][ 1,2,4Jtriazin-8-ones (7 -substituted 6-methyl-6-azapterins) 23, R=Me, NH 2 , SMe, SCH 2 Ph, SCH 2 C 4 H 4 C0 2 H . These were all reasonably good competitive inhibitors of human brain DHPR (47,48 ). They have structures that are closely similar to quinonoid dihydropterin substrates, and should bind in the same orientation at the active site as a quinonoid substrate to give a ternary complex for X-ray studies, but cannot 'turnover' at the active site.
Contrary to earlier findings we showed that it was not dopamine, noradrenaline or adrenaline which inhibited DHPR from human brain, but their oxidation products, the aminochromes, which were the competitive inhibitors (40).
We were looking for bacterial cells which could act as models of the mammalian cells which were deficient in phenylalanine hydroxylase so we examined extracts from E. coli KI2 cells for DHPR activity. These extracts were rich in this activity and we were unable to detect any phenylalanine, tyrosine or tryptophan hydroxylase activities. The DHPR was purified to apparent homogeneity and we compared its properties with those of mammalian DHPRs. Like the human enzyme its molecular weight is the same as the human DHPR subunit molecular wt. (M,-27000 ). When expressing human DHPR in E. coli great care had to be taken because of the presence of intrinsic bacterial DHPR (see below), but these can readily be distinguished because of the pterin-independent K3Fe(CN)o oxidoreductase activity of the latter. Another enzyme which occupied our interest during the past eight or so years has been glycerylether monooxygenase (Scheme 3). It is a membrane bound microsomal protein which had not been extensively studied in the past partly because it required a water insoluble glyceryl ether substrate and partly because rapid and reliable assays for kinetic measurements were not available prior to this work. This was surprising since the enzyme has many similarities with the aromatic amino acid hydroxylases. Its activity should be affected in phenylketonuria due to DHPR and/ or biopterin cofactor deficiencies. It may also have some effect on the cerebro-hepato-renal syndrome of Zellweger in affected children. The monooxygenase is a tetrahydropterin dependent enzyme and uses dihydropteridine reductase to recycle the quinonoid dihydropterin formed in the Pteridines/Vol. 9 / No. 2 Armarego: A Twenty year association with pteridines hydroxylation. The coupled reaction is shown in Scheme 3 . a-Glyceryl ethers 24 are thus hydroxylated at the I '-carbon atom of the long alkyl (C 16, CI8 ) chain by molecular oxygen to produce a hemi-acetal 25 which is then rapidly hydrolysed by acid-base catalysis or enzymically to the corresponding fatty aldehyde and glycerol.
<: We have developed a convenient and rapid spectrophotometric assay which was satisfactory for determining enzyme rates and kinetic parameters (Km, Vmax, V /K) with the usual accuracy required for enzyme kinetics (52,53). The microsomal fraction from rat liver was the source of this monooxygenase for all our work. For our assay it was necessary to solubilise the ether substrates which was achieved with various detergents, but most particularly the non-ionic detergent Mega-IO (N-methyl-N-decanoylglucamide). The assay was used to determine the stoichiometry (54,55), the effects of detergents (56), inhibition ( 55,57) and the nature of glyceryl ether lipid substrates in aqueous buffer for the enzymic reaction (57).
5,6,7,8-Tetrahydrobiopterin was the best pterin cofactor of those that were studied for the monooxygenase, and (+ )-6R-and ( -)-65-6-methyl-5,6, 7,8-tetrahydropterin were about equally active as cofactors ( 54). The kinetic parameters for a large number of lipid ethers were measured and a picture of structure-activity relationships for ether lipid substrates began to emerge (58). Further studies of the kinetic parameters of a variety of ether lipids were used to probe the nature of the active site (59). The lipid membrane was involved in the active site by forming a pocket for binding the long alkyl chain. This was shown by the enzyme activity peaking when the aliphatic chains of the gylceryl ether substrates were CI6 to CI8, and dropping rapidly wiL" 5U :"5trat<:s that had shorter or longer aliphati..: ..:nJ.lI1s. The enzyme was inactivated when the protein was separated from its lipid membrane, but could be reactivated by adding its natural phospholipids, other lipids or certain detergents. The monooxygenase was not sensitive to the absolute configuration at C2 of the glycerol moiety of a-glycerol ethers because natural chimyl alcohol \2-S-3-hexadecyloxypropane-I,2-diol) and natural batyl alcohol (2-S-3-octadecyloxy-propane-I ,2-diol ) were only marginally more active than their non-natural 2R enantiomers (51,59,60). However, at the carbon atom where hydroxylation occurred, i.e. I' C of the alkyl chain, high stereospecificity was observed. By using synthetic 3-hexadecyloxypropane-I,2-diols \ chimyl alcohol) in which I'C was mono-tritiated or mono-deuteriated such that the label replaced the I'-proR and I' -proS hydrogen atoms of the methylene group, clear evidence from tritium release (in chiral tritiated substrates) and enzyme kinetic parameters of deuterium labelled chiral ethers was obtained which showed that the I'-proS hydrogen atom of the methylene group was lost in the oxidation reaction and replaced by a hydroxyl group (61) .
A better understanding of how the glyceryl-ether monooxygenase reaction takes place resulted trom this work as well as providing a clearer picture of the active site of this membrane-bound protein. Briefly, the tetrahydropterin takes up one oxygen molecule from the aqueous buffer to form the 4a-hydroperoxy intermediate 28, X=OOH which binds at the active site of the monooxygenase and transfers one oxygen atom to the metal at the active site. The resulting 4a-hydroxypterin 28, X=OH is released and dehydrates to quinonoid dihydropterin 27 in the aqueous medium by acidbase catalysis or via a dehydratase. The glyceryl ether substrate then presents itself to the active site in the form of micelles (if water soluble, e.g. glycerol-phosphocholine) or mixed micelles (if water insoluble, e.g. batyl alcohol with Mega-IO), and an individual lipid ether substrate molecule binds through its aliphatic chain to the hydrophobic pocket formed by the oxygenated protein 63 and the phospholipid membrane. The individual lipid substrate is then released from the micelle and binds further to the hydrophilic pockets at the active site through the ether oxygen atom as well as a free hydroxy group (if present), and/or a phosphocholine or ethanolamine group attached to the glycerol moiety. The oxygen atom on the metal at the active site then attacks the a-carbon atom of the alkyl chain displacing the 1 '-proS hydrogen atom, probably with retention of configuration, to produce the a-hydroxylated glyceryl ether 25 which dissociates from the enzyme and is hydrolyzed to fatty aldehyde and glycerol in the aqueous medium.
The biochemistry of glyceryl-ether monooxygenase together with background information on the chemistry and biochemistry of glyceryl ethers has been reviewed recently (62) .
Molecular Biology
Structure-activity studies of enzyme-substrate interactions and the kinetic evaluations of the reactions of proteins are severely limited and restricted without the ability to mutate individual amino acid residues at specific positions along a polypeptide chain. Such changes can now be made at will and with great accuracy by site-directed mutagenesis in a comparatively short period of time. These are the reasons why we had to venture into the realm of molecular biology as we wished to know which amino acid residues were associated with the catalytic mechanism of the enzymic reduction of quinonoid dihydropterins by DHPR. At the time that we began molecular biology work we had realised that protonation of the pterin substrate, e.g. 13, was necessary to assist hydride transfer from NADH to N5 of the pterin, as the enzyme catalysed reaction was considerably faster than the non-catalysed reaction at neutral pH. Protonation was most likely to take place at N5, and carried out by a proton donating group close to it at the active site.
In order to prepare substantial amounts of active human DHPR mutants it was necessary to develop an expression vector carrying the DHPR gene (ch DHPR) which could be transformed into, and the protein expressed in, E. coli. We have therefore engineered a cDNA coding for human DHPR at the multiple cloning site of the plasmid pCE30, downstream of the powerful tandem bactereophage A P R and PI. promoters. The plasmid expressed ampicillin resistance and the AC 1857"' gene which allowed transcription of the Pteridines/ Vol. 9/ No. 2 DHPR gene, in the now recombinant plasmid pWLA8, to be controlled by varying the temperature. When transformed into an E. coli K12 strain which was grown at 30°C, very little DHPR was synthesised, but as soon as the temperature was raised to 45°C high levels of the DHPR protein were expressed. The clear supernatant from the broken bacterial cells provided, after naphthoquinone-Sepharose affinity chromatography, pure chDHPR which differed from the human enzyme by not being protected at the amino N-terminal end of the protein . It was free from bacterial DHPR (N-terminal sequence was consistent with the nucleotide cDNA sequence), it was dimeric with subunit M,-27000, but its specific activity was ca four times that of the natural enzyme (63) .
Earlier studies of the irreversible time-dependent inactivation of NADH-free human DHPR by platinum (II) complexes, e.g. K 2 PtC4, and by sulfhydryl reagents revealed that there were at least three cysteine residues in the enzyme subunit. One of these was at, or close to, the active site because addition of NADH protected the enzyme from inactivation and then the enzyme titrated for one less cysteine residue (41). The sequencing of hDHPR cDNA (which was done several years later) showed that the reductase had four cysteine residues at positions 26, 85, 104 and 161 (64) . We had carried out the mutations Cysl04Ser, Cys161Ser and Cys26+85Ser (double mutation) in the DHPR gene in plasmid pWAM (a slightly modified pWLA8), transformed these in an E. coli strain and purified the mutant proteins that were expressed. We then expected that one of the DHPRs would have considerably less activity as the serine OH is a much weaker acid than the cysteine SH, but this was not the case .
The kinetic parameters (Km, V max and V /K) were not seriously diflerent from those of the wild-type enzyme. Thus a cysteine residue did not appear to be the proton source for the reduction. All the mutant DHPRs, however, were more heat sensitive than the wild-type enzyme (45).
When the first crystal structure of rat DHPR-NADH binary complex appeared it was thought that N3 and the NH z of the quinonoid pterin would be exposed to the solvent and that proto nation was mediated by the solvent (45). We felt that this could not be the case and by using the coordinates of the binary complex (kindly provided by Dr Varughese) and those of tetrahydrobiopterin (16, 17) , we used computer graphics to simulate the ternary complex knowing that hydride was transferred from the 4-proS hydrogen Pteridines/ Vol. 9 / No. 2 Armarego: A Twenty year association with pteridines of NADH to NS of quinonoid dihydrobiopterin. The model showed that the phenolic OH of the tyrosine residue at position 1 SO was the most probable proton source, in agreement with the pKa of -10.5 for the conjugate base of tetrahydrobiopterin 29 (formed after hydride transfer to NS of 27) and of the phenolic tyrosine of -10.3. We therefore proceeded to alter this residue. Our previous experience with the cysteine mutations (see above) was that the new DHPRs could not be purified as easily as the wild-type enzyme. We then used another plasmid expression vector (pGEX2T-hDHPR, kindly supplied by Drs Cotton, Howells and Smooker) in which the DHPR gene was fused with the glutathione S-transferase (GST) gene possessing a thrombin cleavage sequence bet\veen the t\Vo enzymes. This expresses a fusion protein of GST and DHPR in which the carboxyl end of GST is linked to the amino terminal of DHPR. The fusion protein that was isolated (using GST -Agarose affinity chromatography and eluting with a buffer containing reduced glutathione) and cleaved with thrombin followed by removal of GST by GST-Agarose chromatography. When the DHPR alone was required the thrombin treatment was performed on the fusion protein bound to the column thereby releasing only DHPR containing trace amounts of thrombin. This DHPR differed from the DHPR expressed by the previous recombinant plasmid (above) in the N-terminal sequences which were GSAAAA-GEAR... and MAAAAAAGEAR... . respectively with virtually identical physical and kinetic properties (66) . Purified DHPRs with the mutations TyrlS0His, TyrlS0Ser, TyrlS0Phe, TyrlS0Glu and Tyr 1 SOLys, were prepared together with precursor GST-DHPR fused protein. The kinetic parameters of the mutant DHPRs and the fusion proteins were evaluated from kinetic data which provided one Vmax (or kcat) value and t\Vo Km values (one for the pterin and one for NADH) derived from one large set of measurements. These values showed that the most likely proton source was tyrosine ISO (66,67, see also 68) . However in the absence of a proton source at residue 1 SO, measurable activities were obtained indicating that a proton may have been relayed via a water molecule (s) from a neighbouring acidic amino acid group in the enzyme. The kinetic parameters that were obtained using quinonoid RS-6-methyl-7 ,8( 6H)-dihydropterin and natural quinonoid 6R-7 ,8 ( 6H)-dihydrobiopterin were not always consistent with each other meaning that the mutant enz\,mes can behave differently with non-natural pterin cofactors. Also, the kinetic parameters from the fusion proteins may be completely different in relative order and magnitude from those of the unconjugated proteins and should never be extrapolated to them. With the availability of natural tetrahydrobiopterin there is no excuse for using non-natural cofactors for such m easureme nts (66) .
In vitro Site-directed metagenesis of hDHPR was also carried out to produce the separate changes Gly151Ser, Gly23Asp and a threonine insertion at position 123, all of which have been found in defective children. The enzyme activities of the first two mutant DHPRs were consistent with the severity of the disease . The third mutant DHPR could not be obtained in pure state due ro proteolysis but its fusion protein with GST was enzymically active and the child with this defect, now a teenage girl, is healthy though mentall y retarded. Here again only the data with the natural cofactor should be looked at as the kinetic data from quinonoid 6-methyl-7 ,8( 6H)-dihydropterin could be misleading (66, 67) .
We wished to scree n a mouse genomic library in order to make a mouse in which the DHPR gene was 'knocked out', i.e. a mouse model for DHPR deficie ncy, and decided to isolate mouse DHPR cDNA and sequence it for comparison with the human enzyme. This was done by screening a mouse cDNA library with a portion of the human cDNA gene which was randomly labelled with 32p . A consensus sequence was o btained for the coding region of the g ene from sequencing nine clones, six of which had DNA in the 5' and 3' tlanking regions of the gene. Of the 720 nucleotides in the mouse DHPR cDNA only 89 were different from the human gene and 31 from the rat gene. However the differences in the translated amino acid sequences for the human and rat proteins were 15 and 6 respectively and the changes were quite conservative, consistent with this enzyme being an important "house-keeping" protein . On the other hand, the seque nces in the 5 ' and 3 ' flanking regions of the human, rat and mouse DNAs were irrecognisably differe nt. The cDNA was engineered into a pGEX vector and expressed as a GST fusion protein trom which the mouse DHPR with the N-terminal sequence MAASGEAR. .. . ( compare with above) was obtained. The kinetic parameters with NADH and the natural cofactor or quinonoid 6-methyldihydropterin for this enzyme were similar to those measured for the DHPR which was purified from mouse liver (69 ) .
We attempted to identif)r the gene that codes for the E. coli DHPR described near the end of the Biochemistry section above, but isolated a chromosomal DNA fragment that directed the synthesis of two soluble proteins . We identified the larger protein (M, 46000) as serine hydroxym e thyltransferase and the smaller protein (M, 44000) was described previously as the product of an unknown gene. We over-produced the latter protein in E. coli and found that it had DHPR activity and was yellow in colour but was distinctly different from the bacterial DHPR that we had purified before. Its visible spectra indicated that it was a b-type haemoprotein and its DNA sequence had considerable similarity with the Vitreoscilla haemoglobin . We had thus shown that E. coli had a soluble h aemoglobin-like protein which we named as the product of the hmp gene (from haemoprotein ) (70 ) .
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Introduction
In mammalian cells, the de novo biosynthesis of H 4 -biopterin has been elucidated over the last 15 years, and recently biosynthetic enzymes have § Author to whom correspondence should be addressed.
This article is dedicated to Prof. Wolfgang Pfleiderer. been cloned from mammalian and insect sources. Three enzymes are involved in synthesizing H 4 -biopterin (10, 11, 12, 13, 25) . GTP cyclohydrolase I produces Hrneopterin triphosphate (HzNTP) from GTP (25) . The sequential action of 6-pyruvoyltetrahydropterin synthase (PTPS) and sepiapterin reductase yields the final product H 4 -biopterin. Besides or instead of sepiapterin reduc-tase, aldose reductase and lor carbonyl reductase, can also catalyze the reduction steps (15) . Until recently, it was thought that the reduction of H 2 -biopterin to H 4 -biopterin by dihydrofolate reductase was the final reaction of the pathway . However, since the biosynthesis of H 4 -biopterin occurs in the absence of dihydrofolate reductase or in the presence of dihydrofolate reductase inhibitors, this Hrpterin pathway must be incorrect . It was then proposed, and evidence was presented, that the true intermediates between H 2 NTP and H 4 -biopterin are actually H 4 -pterins, namely pyruvoyl-H4-pterin (PTP) and lactoyl-H 4 -pterin (LTP).
Pteridine biosynthesis in microorganism had not been studied as much as pteridine biosynthesis in mammalian cells. The activity of biosynthe tic enzymes found in animal cells was detected in some microorganisms. GTP cyclohydrolase I, the enzyme catalyzing the first step of pteridine synthesis from several bacteria has been described, and the enzyme has been purified to apparent homogeneity from E. coli and Bacillus subtilis (20, 25) . In E. coli, the gene which encodes GTP cyclohydrolase was cloned and analyzed in relation to the regulation of pteridine biosynthesis.
A new pteridine was purified and identified from Chlorobium limicola, a photosymthetic Green Sulfur bacterium. This pterin compound is named as limipterin after the species name limicola (4) . The complete structure of limipterin is proposed as [I-0-(L-erythro-biopterin-2 r -yl)-I3-N-acetyl glucosamine]. The molecular formula is C17H240~N6 and it contains a biopterin and a glucosarnine moiety. The attachment of N-acetylglucosamine was confirmed by acid hydrolysis as well as enzymatic hydrolysis experiment using 13-N -acetylglucosaminidase. Lirnipterin was susceptible to this enzyme, which is highly specific for l3-glycoside linkage of N-acetylglucosamine. The oxidation state of native limipterin was established by the differential iodine oxidation experiments. It could be estimated that >93% of limipterin is maintained as tetrahydro form in vivo (4) .
Based on the constructed structure , the pathway leading to the biosynthesis of lirnipterin was investigated. GTP cyclohydrolase, PTP synthase, and sepiapterin synthase were all present in the 30-80% ammonium sulfate fraction of Chlorobium extract. The enzyme activity that produce tetrahydrolimipterin using tetrahydrobiopterin and UDP-N-acetyl-glucosamine as substrates existed in 40-60% ammonium sulfate fractions. This enzyme absolutely requires manganese ion and dithiothreitol. From these results, the overall biosynthetic pathway for H 4 -lirnipterin could be proposed (Fig. 1)  (9) . In this report we described purification and characterizations of the enzymes involved III limipterin biosynthesis in Chlorobium limicola.
Materials and Method
Microorganism and cultivation
Chlorobium limicola f. thiosulfatophilum NCIB 8327 was supplied by S. Sirevag (University of Oslo, Norway) and grown photoautotrophically under the light intensity of 50-80 par. for 7 to 10 days at 30°C. The organism was cultured in narrow neck polycarbonate carboys each containing 19. 
Limipterin synthase assay
The reaction mixture containing 0 .1 M PIPES (pH 6.8 ), 10 mM MnCl z , 10 mM Glucose , 12 U Glucose oxidase, 100 IlM UDP-GlcNAc, 200 IlM H 4 -biopterin, 10 mM DTT, and enzyme fraction was incubated at 3TC for 1 hr. The final reaction volume was 40 Ill. The reaction was terminated by adding 20 III of acidic iodine solution ( 1 % 121 2% KI in 1 M HC1 ) and left for 2 hrs at room temperature in the d ark. The precipitate was removed by microcentrifugation at lS,OOO x g for S min, followed by adding IS III of 2% ascorbic acid. After microcentrifugation, S III aliquot was analyzed with C18 NovaPak HPLC column using 10 m~l potassium phosphate (pH S.S), 2 .S mM EDTA as mobile phase at a flow rate of 1.0 m1/ min . The fluorescence of limipterin was monitored at the wavelength of 4S0 nm upon excitation at 350 nm . One unit of LS was defined as the amount of enzyme which produced 1 nmol limipterin per min under the standard assay condition.
D etermination of protein
The protein concentration was determined according to the method proposed by Bradford (2 ), using bovine serum albumin as a standard protein .
Purification of the biosynthetic enzymes of H 4 -limipterin from Chlorobium limicola
Unless otherwise indicated, all procedures were carried out in the cold room, and buffers were prepared fresh. All buffers contained 2.S mM dithiothreitolor 10 mM l3-mercaptoethanol to maintain anaerobic condition .
Preparation of crude extract
The cells ( 100 g) were suspended in 8 volumes Pteridines/ Vol. 9 / N o. 2 Kang et at.: Biosynthetic enzymes of tetrahydrolimipterin of 100 mM PIPES buffer (pH 6.8), containing 2.S mM DTT. The cell suspension was sonicated anaerobically at successive 1 second sonication and S seconds intervals for 30 min and then centrifuged at lS ,OOO x g for 40 min. Saturated ammonium sulfate solution containing 2.5 mM DTT was added to the supernatant (950 ml ) fo r fractionation.
Purification of GTP cyclohydrolase J
The 20-40% ammonium sulfate precipitate was dissolved in SO mM Tris-HCI buffer (pH 8 .0), containing 10 mM l3-mercaptoethanol. The material ( 24 ml ) was dialyzed twice against SOO volumes of 20 mM Tris-HCl buffer (pH 8.0) containing 10 mM l3-mercaptoethanol (buffer G) .
The dialy zed sample (26 ml) was applied to a column of DEAE-sephadex (Vt=80 ml) equilibrated in advance with buffer G. The column was washed with the same bufter and developed with a linear gradient of 0.0 -1.0 M NaCI in a total volume of 300 ml at a flow rate of 40 mljh. Active fractions ( 0.6-0.7 M NaCl) were co llected and dialyzed twice against 500 ml of 20 mM TrisHCl (pH 8.0 ) buffer containing 2 .S mM EDTA, and 10 mM l3-mercaptoethanol. Dialyzed fractions ( 13 ml) were loaded onto a column of GTPagarose (0.8 x 6 cm, Vt=3 ml) which had been equilibrated with the dialysis buffer. The column was washed with the same buffer and developed successively with ( 1) 20 mM Tris-HCI (pH 8 .0), 2.5 mM EDTA, 10 mM l3-mercaptoethanol, 0.2 M NaCl; (2 ) the equilibration bufter; (3) 20 mM Tris-HCI buffer (pH 8.0), containing 2 .5 mM EDTA, 10 mM l3-mercaptoethanol, and 1 mM GTP . Most of the en zyme activity was recovered in the final elution buffer.
Partial Purification of PTP synthase and sepiapterin reductase
PTP synthase-The 50-70% ammonium sulfate precipitate was dissolved in 100 mM PIPES buffer (pH 6 .8 ) containing 2.5 mM DTT, and was applied to a column of Ultrogel AcA 44 ( 3 .0 x 85 em, Vt=SOO ml ). The column was developed with 20 mM PIPES buffer (pH 6.8) containing 2 .S mM DTT (buffer P ). The fractions containing enzyme activity were combined and loaded onto a Reactive-Yellow column (3.0x 4 .S cm, Vt=25 ml) that had been equilibrated with bufier P. The column was washed with the same buffer and the proteins were eluted with a linear gradient of 0 .0-1.0 M NaCI in a total volume of 80 mI . The active fractions were collected and stored at -80°C until used.
Sepiapterin reductase-The 30-50% ammonium sulfate precipitate was dissolved in 100 mM PIPES buffer (pH 6.8) containing 2.5 mM DTT and applied to a column of Ultrogel AcA 44 (3. Ox 85 cm, Vt=500 ml). The column was developed with buffer P . The active fractions were collected and subjected to chromatography on Reactive-Brown Agarose ( 3.0 x 5 em, Vt=30 ml) pre-equilibrated with buffer P . The column was washed with the same buffer and developed with a gradient of 0.0-1.0 M NaCI in a total volume of 120 ml at a flow rate of 40 ml/ h.
Purification of limipterin synthase
Saturated ammonium sulfate solution containing 2.5 mM DTT was added to the crude extract (940 ml) to obtain 40-60% fractions. The ammonium sulfate precipitate was dissolved in 100 mM PIPES buffer (pH 6.8) containing 2.5 mM DTT and applied to Sephacryl S100 (3. 0 x 90 em, \ Tt =550 ml) pre-equilibrated with buffer P and de-\'eloped with the same buffer at a flow rate of 35 mljh. The active fractions were pooled and loaded onto an activated Methotrexate-agarose . The column (0.8 x 10 em, Vt=5 ml) which had been equilibrated with buffer P was washed with the same bufier and developed successively with 1) 0.2 M NaCl, and 2) a linear gradient of 0.2-1.0 M NaCl. Solid NaCI was added to the pooled active fractions until 1 M concentration was reached . The sample was then applied to Phenyl-Sepharose (1.8 X 5.8 em, 10 ml) that had been equilibrated with 20 mM PIPES buffer (pH 6.8) containing 2.5 mM DTT, and 1 M NaCl. The column was washed with the equilibration bufier and developed with a gradient of 1.0-0.0 M NaCI in a total volume of 40 m!. The enzyme fractions were collected and dialyzed with 2 liter of 20 mM Tris-HCI (pH 7.4), 2.5 mM DTT. Dialyzed flow-through fractions (the active fractions) were applied to Mono-Q column (Vt=1 ml) pre-equilibrated with 20 mM Tris-HCl (pH 7.4), 2.5 mM DTT using FPLC system. The column was washed with the equilibration buffer and developed with a gradient of 0 .0-1.0 M NaCI in a total volume of 25 m!. Salt eluted active fractions were concentrated to a small volume (400 f.ll) using Centricon (M. W. cutoff 30,000 dalton) . Two hundred f.ll of the concentrated sample (total volume=400 f.ll ) was then applied to Superdex 75 73 (separation range=5,000-75,000 dalton, Vt=24 ml) equilibrated with 50 mM PIPES buffer (pH 6.8) containing 2.5 mM DTT at a flow rate of 0.4 mll min . The column was developed with the same buffer at the same flow rate . The active fractions were pooled and stored at -80°C until used.
Molecular weight and subunit size of limipterin synthase
The molecular weight of the enzyme was determined by gel filtration chromatography on a Superdex 75 (Vt=24 ml, Pharmacia). The column was calibrated with Blue dextran (2,000 kd), albumin from bovine serum (68 kd), albumin from hen egg (45 kd), chymotrypsinogen A (25 kd) and cytochrome c ( 12.5 kd). SDS-PAGE was performed on 12.5% polyacrylamide gels. As standard marker proteins, myosin (220 kd ), phosphorylase b (97.4 kd), BSA (66 kd), ovalbumin (46 kd), carbonic anhydrase (30 kd), trypsin inhibitor (21. 5 kd) and lysozyme ( 14 .3) were used. After electrophoresis, protein band was visualized with the silver staining method according to Wray (23) .
Enzymatic synthesis of Hrlimipterin from GTP
Preparation of dihydroneopterin triphosphate-GTP-agarose eluant was used as enzyme source. The reaction mixture contained 0.1 M Tris-HCI buffer (pH 8.0), 0.1 M NaCl, 3 mM GTP , 5 mM EDT A and purified GTP CHase I in a total volume of 500 f.ll and was incubated at 42"C t()f 2 .5 hours. The dihydroneopterin triphosphate produced was used as substrate for the subsequent biosynthesis experiments. At intervals of 0.5, 1 and 2.5 hours, 20 f.ll of reaction mixture was used for product analysis. Ten f.ll of 5 N TCA and 25 f.ll of iodine solution ( 1% 1 2 / 2% KI) were added to the mixture . After 30 min of oxidation, 13 f.ll of 2 % ascorbic acid was added to destroy excess iodine. The aliquots were analyzed with f.lBondaPak C18 column using 2% methanol as solvent. To confirm the reaction product, each 20 f.ll sample was mixed with 1 U alkaline phosphatase and incubated for 1 hour. Ten f.ll of 5 N TCA and 25 f.ll of iodine solution ( 1% Iz/2% KI) were added to the mixture . After 30 min oxidation, 13 J..lI of 2% ascorbic acid was added and analyzed with f.lBondaPak C18 column using 2% methanol as solvent.
Preparation of PTP from HjVTP-PTP synthase was partially purified through Ultrogel AcA34 and Reactive-Yellow dye-binding gel and sepi-apterin reductase was isolated by using Ultrogel AcA44 and Reactive-Brown agarose gel as desciebed previously. Partially purified PTP synthase was mixed with 0.1 M Tris-HCl buffer, pH 7 .4 containing 25 mM MgCI 2 , 420 f...LM H 2 NTP, 10 mM DTT in a total volume of 20 f...L1. The mixture was incubated at 37"C for 2 hours. Ten f...ll of 5 N TCA and 50 f...Ll of 1% 1 2 / 2% KI solution were added to convert 6-pyruvoyl tetrahydropterin to pterin in acidic conditions. After 60 min, the insoluble material was removed by centrifugation at 13,000 x g for 10 min and excessive iodine was destroyed by the addition of 20 f...ll of 2% ascorbic acid. The acidic supernatant was applied to f...LBondaPak C18 HPLC column using 20 mM potassium phosphate (pH 5.5), 2.5 mM EDTA as solvent.
Preparation of Hrbiopterin from HflTP-Standard reaction mixture included 0.1 M Tris-HCI buffer (pH 7 .4) containing 25 mM MgCI 2 , 420 1-1,\1 H2NTP, 10 mM DTT, 1 mM NADPH, PTP synthase (Affi-Yellow fractions), and SR (AffiBrown fractions) in a total volume of 40 f...L1. Twenty 1-11 of 5 N TCA and 100 f...ll of 1% 1 2 / 2% KI '-olu tion were added to the mixture. After 60 min, the insoluble material was removed by centrifugation at 13,000 x g for 10 min and excessive iodine was destroyed b y the addition of 40 f...LI of 2% ascorbic acid . The acidic supernatant was applied to f...lBondaPak C18 HPLC column using 20 mM potassium phosphate buffer (pH 5 .5) containing 2.5 mM EDTA or H 2 0 as solvent .
In vitro synthesis of tetrahydrolimipterin from H z NTP-The reaction mixture containing 0.1 M Tris-HCI buffer (pH 7 .4), 20 mM MgClz, 20 mM MnCI 2 , 276 f...LM H 2 NTP, 1 mM UDP-N-acetylglucosamine , 10 mM DTT, 1 mM NADPH, PTP synthase (Alli-Yellow fractions ), sepiapterin reductase (Afti-Brown fraction), and limipterin synthase (Superdex 75 fractions ) in a total volume of 80 f...Ll was incubated at 37"C for 2hrs. The product was analyzed by the same method described previously.
Results
Localization of enzymes involved in the biosynthesis of Hrlimipterin
Based on the constructed structure, the biosynthetic pathway for limipterin was investigated. Enzyme activity of GTP cyclohydrolase I, PTP synthase, and sepiapterin reductase were detected in the 30-80% ammonium sulfate fractions. Each enzyme was partially purified from Chlorobium limicola. The enzyme activity that produced H 4 -limipterin using H 4 -biopterin and UDP-N-acetylglucosamine as substrates was present in 40-60% ammonium sulfate fractions. In order to determine in vivo localization, each enzyme activity was examined in cell wall-membrane fraction and cytosolic fraction. As shown in Table 1 , all the biosynthetic enzyme actIvlUes of H 4 -limipterin and pteridine compounds were found in cytosolic fractions. Limipterin synthase activity also was found in the cytosol unlike the other well-known sugar transferases that are present in the membrane fraction (14, 19, 21) .
Purification and biochemical characterization of GTP cydohydrolase I
Majority of GTP cyclohydrolase actiVIty was detected in 0-40% ammonium sulfate precipitates. Further purification was achieved by DEAE-sephadex and GTP-agarose chromatography. A SWTI- Table 1 #Cytosolic fractions were prepared as supernatant .1fter <:enrrih.lgation at 50,000 x g for 40 min.
Ptcridines/ Vol. 9 / No. 2 Table 2 . An overall purification of 220 fold was obtained with the most effective step being GTP-agarose . Unlike the E. coli and mammalian GTP cyclohydrolases, the Chlorobium enzyme did not bind to UTP-agarose . The dialyzed ammonium sulfate fractions were applied to a DEAE-Sephadex column equilibrated in advance with 20 mM Tris-HCI (pH 8.0), 10 mM I)-mercaptoethanol. Active fractions were eluted at 0 .6-0.7 M KCI. After dialysis, the sample was loaded to a column of GTPagarose pre-equilibrated with the Tris, I)-mercaptOethanol buffer containing 2.5 mM EDTA. The enzyme was eluted with 1 roM GTP in the equilibration buffer. The optimum pH and tem- perature for the GTP CHase I of Chlorobium limicola were found to be pH 7.5-S.0 ( Fig. 2A) and 60°C (Fig. 2B) .
Purification of PTP synthase
PTP synthase was purified from 50-70% ammonium sulfate precipitate through Ultrogel AcA 44 and Reactive Yellow-agarose chromatography. A total purification of 33 fold was achieved, as shown in Table 3 . The ammonium sulfate precipitate was dissolved in 100 mM PIPES (pH 6.S), 2 .5 mM DTT and applied to a column of UItrogel AcA 34. The fractions containing enzyme activity were pooled and loaded onto a Reactive- Yellow column. The active fractions were eluted in a salt concentration of 0.4-0.5 M.
Purification of sepiapterin reductase
Sepiapterin reductase activity was detected mainh' at 30-50% ammonium sulfate precipitates. Further purification was achieved by Ultrogel AcA 44 and Reactive Brown-agarose chromatography. A summary of the purification is presented in Table  4 . An overall purification of 89-fold was achieved. The ammonium sulfate precipitate was dissolved in 100 mM PIPES bufier (pH 6.8) containing 2.5 mM DTT and applied to a column of Ultrogel AcA 44. The fractions containing enzyme activity were collected and loaded to a Reactive-Brown column. The active fractions were eluted at 0.5-0.6 M NaCl and separated from the major protein peak.
Purification of limipterin synthase
A summary of purification is shown in Table 5 . The enzyme was purified by ultracentrifugation, ammonium sulfate precipitation (40-60%), Sephacryl S100, methotrexate-agarose, phenyl-sepharose , mono-Q and Superdex 75 chromatography. By this procedure, the enzyme was purified to 3610-fold with an overall recovery of 9.4%. After dialysis against 20 mM PIPES buffer (pH 6.8) containing 10% glycerol and 2 .5 mM DTT, the purified enzyme was stable for months at -80 n C. The ammonium sulfate precipitate was applied to Pteridines/ Vol. 9 / No. 2 a Sephacryl S100 column which had been previously equilibrated with 10 mM PIPES buffer (pH 6.8) containing 2.5 mM DTT. The active fractions which were separated from major proteins and pigments were pooled and loaded to a pre-activated Methotrexate-agarose. The enzyme activity appeared at the 0.2 M NaCI. (Fig. 3) . Mter the addition of solid NaCl to 1 M, the enzyme solution was applied to phenyl-sepharose. The enzyme was eluted in the flow-through frac- shows that active fractions were eluted at 0 .6-0.7 1\1 NaCl. Active enzyme solution was concentrated to a small volume (400 f..ll) using Centricon (cutoff MW=30,000 dalton) and applied to Superdex 75. The column was developed with 50 mM PIPES buffer (pH 6 .8) contammg 2.5 mM DTT using FPLC system. The activity appeared at the molecular weight range of about 46,000 dalton (Fig. 5) . Active fractions were collected and stored at -80 n C until used.
Characteristics of purified limipterin synthase
Since it was important to maintain anaerobic condition for limipterin synthase activity, either 2-mercaptoethanol or dithiothreitol was added to all buffers during purification and enzyme assays. The biochemical characteristics such as reaction products, substrate specificity, enzyme kinetics, etc. were investigated for this enzyme . 
Reaction product
To confirm the catalytic aCtlVIty of limipterin synthase, the enzymatic products were analyzed by reversed phase HPLC . The retention time of the reaction product was the same as that of limipterin purified from Chlorohium. The enzymatic product was hydrolyzed in cone. trifluoroacetic acid for 3 hours at room temperature and analyzed again by HPLC. As shown in Fig. 6 , the hydrolytic product was biopterin that was a substrate in the reaction mixture before it was treated with limipterin synthase.
Substrate specificity and regulators
Limipterin synthase catalyzes the condensation of H 4 -biopterin with UDP-GlcNAc to form the pterin glycoside. We examined the ability of the enzyme to use various pteridines, and other forms of UDP-sugars. Table 6 shows that UDP-N-acetylglucosamine was the only choice for the sugar moiety whereas both dihydrobiopterin and its tetrahydro-form could be used for the pterin. The fully oxidized-form was not the substrate for this enzyme. We also studied the regulation of the activity by substrate analogues such as UDP-N-acetylgalactosamine, UDP-galactosamine etc. and other structurally related compounds. UDP inhibited the enzyme activity to over 70% at the concentration of 300 I-J.M and other product analogues including UTP exhibited inhibitory efkcts on limipterin synthase (Table 7) . UDP-N-acet:ylgalactosamine and UDP-galactose also had in- 
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acetylglucosamine calculated irom double-reciprocal (Lineweaver-Burk) plot were 42 ~M and 124 ~M respectively (Fig. 8) . Considering a set of intersecting lines patterns in the double-reciprocal plot, limipterin synthase is supposed to form a ternary complex during the course of the reaction. Cations were added in the form of chloride activity was higher with organic buffers such as PIPES, HEPES and Tris-HCI than potassium phosphate buffer. The optimum temperature for the reaction was 3rC (Fig. 9B) .
Optimum pH and temperature
Effect of metal ions and dithiothreitol
The enzyme required manganese ions for maximal activity, as shown in Table 8 . The magnesium ion can replace the role of manganese ion to some extent. This result agreed to the fact that mammalian sugar transferases require manganese ions to bind with sugars. The activity, however, was inhibited by MnCl 2 at the concentration higher than 10 mM. Limipterin synthase was most active in the presence of 10 mM DTT.
Molecular weight and subunit size
The molecular weight of limipterin synthase was calculated to be 46,000 dalton by comparing its mobility with those of standard proteins on a calibrated Superdex 75 column (Fig. 10) . In SDS-PAGE, the enzyme fraction generated no visible protein bands of lower molecular weight except one having apparent molecular weight of 45,000 dalton (Fig. 11) . The results indicated that limipterin synthase of Chlorobium limicola most likely exists as a monomer.
Analysis of biosynthetic intermediates of H 4 -limipterin in vitro
Identification of H~TP-It is known that all naturally occurring pteridines originate from GTP by the action of GTP cyclohydrolase 1. In order to identify the enzymatic product of GTP CHase I, the mixture of Chlorobium GTP CHase I reaction was analyzed by fluorescence spectroscopy and the spectrum was compared with the emission spectra of authentic D-erythro-neopterin ( Fig. 12: A,B,C ) . As shown in Fig. 12 : E, G, the iodine oxidation product of Chlorobium GTP CH I under the acidic condition was neopterin triphosphate , and the alkaline-phosphatase treated reaction product was neopterin. The results indicate that the reaction product of the Chlorobium limicola GTP CHase I is D-erythro-dihydroneopterin triphosphate.
Detection of PTP-Using H lNTP as a substrate, the reaction product of Chlorobium PTP synthase was analyzed by HPLC, using the method of Hatakeyama. Because 6-PTP is converted to pterin ' ...... (""'"') figure 12. Fluorescence analyses of the reaction product of Chlorobium and E. coli GTP cyclohydrolase 1. A: emission spectra of standard neopterin, B: emission spectra of reaction product by E. coli GTP CHase I, C: emission spectra of reaction product by Chlorobium GTP CHase I, 0: HPLC analysis of 0 min control, E: HPLC analysis of reaction product of Chlorobium GTP CHase 1, F: HPLC analysis of pteridine standards I ) neopte rin triphosphate 2) neopterin 3 ) biopterin 4) pterin , G : HPLC analysis of the reaction mixture upon alkaline phosphatase treatment of E fraction. Column: I-lBondaPak C 18, mobile phase: 2 % MtOH, flow rate: 1.0 mljrnin .
In acidic iodine oxidation condition, the reaction product of Chlorobium PTP synthase was identified as pterin. As shown in Fig. 13 , this product was the same as the one that was produced by Drosophila PTP synthase (purified from Drosophila melanogaster by the method of Park et al.) . The enzyme absolutely requires magnesium ions for its activity.
Biosynthesis of Tetrahydrobiopterin -When H 2 NTP was incubated with Chlorobium PTP synthase and Chlorobium sepiapterin reductase in the presence of MgCl 2 and NADPH, biopterin was found to be one of the products after acidic iodine oxidation (Fig. 14, C) When all biosynthetic enzymes and cofactors such as GTP CHase I, PTPS, SR and limipterin synthase, two metal ions (Mn 2 +, Mg2+), antioxidant (DTT) and NADPH existed in the reaction mixture, the final product, limipterin could be synthesized efficiently upon incubation at 3TC . (Fig. 14, D) . The intermediates as well as the final product, limipterin, could also be identified using thin layer chromatography (Fig. 15) . The results of the TLC analysis of the biosynthetic intermediates of limipterin are summarized in Table 9 .
Biosynthesis of Hr limipterin in vitro
Discussion
Little information is available concerning the biosynthesis of unconjugated pterins in microorganisms. It was reported that various microorganisms, especially a number of photosynthetic bacteria contain relatively high amount of pterin The pathway leading to the biosynthsis of limipterin in Chlorobium limicola was first proposed by Kang and others (9) . It was shown that Chlorobium, like the case of mammalian systems, uses the same set of enzymes, i.e, GTP cyclohydrolase I, 6-PTP synthase and sepiapterin reductase for the synthesis of biopterin part of the pterin glycoside. Biosynthetic intermediates of the pathway such as Hz-NTP, 6-PTP, and H 4 -limipterin were identified by HPLC and TLC methods . The enzyme that condenses H4 -biopterin with Nacetylglucosamine was purified and some of the properties were examined. The enzyme uses H 4 -biopterin and UDP-N-acetylglucosamine as substrate and requires manganese ions and a reducing agent, dithiothreitol to exhibit maximal activity. It is interesting to see that some other sugar transferases <.. ;0 prefer manganese ion rather than magnesiUIJl for catalysis. Limipterin syn- thase is a monomeric protein with a molecular weight of about 46,000 dalton.
It was demonstrated that L-threobiopterin glycoside of N -acetylglucosamine is present in Chlorobium tepidium in relatively large amount (2-5 /-Lmol per gr dry weight) . The compound, [1-0-(L-threo-biopterin-2 '-yl)-I3-N -acetyl glucosamine], was designated as tepidopterin after the species name of the Chlorobium genus (5). Limipterin synthase, the final enzymes of the H+-limipterin synthesis could produce H 4 -tepidopterin from Dthreo-5,6,7,8-tetrahydrobiopterin and UDP-N-acetylglucosamine. The epimerization can occur either at the biopterin level or at the pterin glycoside level. We are currently investigating the epimerization enzymes that convert H4 -L-erythrobiopterin to its threo form, H 4 -L-threobiopterin ( dictyopterin ), or H4 -limipterin to H 4 -tepidopterin. A plausible pathway for the enzymatic synthesis of H 4 -limipterin and H 4 -tepidopterin is depicted in Fig 16. Although tetrahydro form of limiptcrin can be used efficiently as a cofactor for mammalian aromatic amino acid hydroxylases (9), the biological high concentration led u s to suspect that it might h ave another impo rtant roles in the photosynthetic species. We are investigating whe ther H 4 -limipte rin is involved in photoreception, phototransduction, re dox process in photosynthetic dark reactions or in the biosynthesis of cell wall component of the Chlorobium species .
Introduction
Not surprisingly, numerous examples exist which demonstrate the profound effect of the presence of a dihydro or tetrahydro structure on chemical and biological functions exerted by pterin derivatives. To name just a few striking examples recently described: while reduced pterin derivatives such as, e.g., 7,8-dihydroneopterin or 5,6,7,8-tetrahydrobiopterin are strong scavengers of luminol-dependent chemiluminescence induced by oxygen or chlorine free radicals, their aromatic counterparts neopterin and biopterin strongly enhance light output from such systems (1, 2 of free radical generating disinfectants such as hydrogen peroxide or chloramine-Ton bacteria, but the reduced derivatives efficiently suppress bacterial growth inhibition by the same chemicals (1,3).
While we have good evidence that scavenger effects of reduced pterins are generally accompanied by chemical reduction of the free radicals involved, the observed enhancer effects remain wlexplained (4). Transition metal ions seem to be somehow involved (5) but no definite explanation has been given.
By these and other recent observations, we have become interested in a more detailed insight into the electronic structure of pteridine derivatives. As an initial step, we have performed ab initio calculations on pterin and its reduced counterparts, 7,8 -dihydropterin and 5,6,7,8-tetrahydropterin. The aim was to elucidate details of the electronic charge densities and particularly of the electrostatic potentials of these substances serving as '"model compounds" for other chemically or biologically important pteridine derivatives.
